| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.14 | 0.005 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.15 | 0.007 |